Splenectomy before tumor inoculation prolongs the survival time of cachectic mice
- PMID: 7489562
- PMCID: PMC11037671
- DOI: 10.1007/BF01516994
Splenectomy before tumor inoculation prolongs the survival time of cachectic mice
Abstract
The effects of splenectomy on the development of cachexia, tumor growth and animal survival were studied in tumor-bearing CDF1 mice. Mice were inoculated with two subclones of colon 26 adenocarcinoma, clone 20 (with a potent capacity to induce cachexia) and clone 5 (without such activity), and underwent splenectomy before or after tumor inoculation. Splenectomy significantly prolonged the survival of mice bearing clone 20 when it was performed prior to tumor inoculation, although the progression of cachexia and tumor growth were not affected. The survival rate was higher in splenectomized than it was in nonsplenectomized mice 20-40 days after tumor inoculation. Such effects on survival were not observed, however, in mice splenectomized after inoculation with clone 20 or in mice that underwent splenectomy either before or after inoculation with clone 5. The decrease of peripheral blood lymphocyte count observed in mice bearing clone 20 was magnified when splenectomy was performed before tumor inoculation, but the serum levels of tumor necrosis factor and interleukin-6 were comparable. These results indicate that cancer death from cachexia is not directly attributable to enhanced catabolism. The mechanism by which splenectomy ameliorates the survival of cachectic mice remains to be studied, although several changes observed in the splenectomized mice after inoculation, including decreases in the peripheral blood L3T4+ cells and Lyt-2+ cells on the 9th day and 15th day respectively, and increase in the L3T4+/Lyt-2+ cell ratio on the 15th day suggest the involvement of the modified host's immune response.
Similar articles
-
Characterization of mice bearing subclones of colon 26 adenocarcinoma disqualifies interleukin-6 as the sole inducer of cachexia.Jpn J Cancer Res. 1994 Nov;85(11):1124-30. doi: 10.1111/j.1349-7006.1994.tb02917.x. Jpn J Cancer Res. 1994. PMID: 7829397 Free PMC article.
-
Manifestations of cancer cachexia induced by colon 26 adenocarcinoma are not fully ascribable to interleukin-6.Int J Cancer. 1995 Jul 28;62(3):332-6. doi: 10.1002/ijc.2910620317. Int J Cancer. 1995. PMID: 7628876
-
Molecular analysis of the cytokine network involved in cachexia in colon 26 adenocarcinoma-bearing mice.Cancer Res. 1995 Feb 15;55(4):921-7. Cancer Res. 1995. PMID: 7850809
-
Effect of splenectomy on the growth of murine colon tumors.J Surg Oncol. 1983 Feb;22(2):73-6. doi: 10.1002/jso.2930220202. J Surg Oncol. 1983. PMID: 6823129
-
Changes in monoamine turnover in the brain of cachectic mice bearing colon-26 tumor cells.J Neurochem. 1998 Jan;70(1):260-7. doi: 10.1046/j.1471-4159.1998.70010260.x. J Neurochem. 1998. PMID: 9422370
Cited by
-
Splenectomy has opposite effects on the growth of primary compared with metastatic tumors in a murine colon cancer model.Sci Rep. 2024 Feb 24;14(1):4496. doi: 10.1038/s41598-024-54768-5. Sci Rep. 2024. PMID: 38402307 Free PMC article.
-
Long-term risks after splenectomy among 8,149 cancer-free American veterans: a cohort study with up to 27 years follow-up.Haematologica. 2014 Feb;99(2):392-8. doi: 10.3324/haematol.2013.092460. Epub 2013 Sep 20. Haematologica. 2014. PMID: 24056815 Free PMC article.
-
Expanding spectrum of the association between Type 1 Gaucher disease and cancers: a series of patients with up to 3 sequential cancers of multiple types--correlation with genotype and phenotype.Am J Hematol. 2010 May;85(5):340-5. doi: 10.1002/ajh.21684. Am J Hematol. 2010. PMID: 20425796 Free PMC article.
-
Myeloid PTEN deficiency impairs tumor-immune surveillance via immune-checkpoint inhibition.Oncoimmunology. 2016 Mar 28;5(7):e1164918. doi: 10.1080/2162402X.2016.1164918. eCollection 2016 Jul. Oncoimmunology. 2016. PMID: 27622019 Free PMC article.
-
Trabectedin and Lurbinectedin Extend Survival of Mice Bearing C26 Colon Adenocarcinoma, without Affecting Tumor Growth or Cachexia.Cancers (Basel). 2020 Aug 17;12(8):2312. doi: 10.3390/cancers12082312. Cancers (Basel). 2020. PMID: 32824440 Free PMC article.
References
-
- Beutler B, Cerami A. Cachectin and tumor necrosis factor as two sides of the same biological coin. Nature. 1985;320:584. - PubMed
-
- Black K, Garrett IR, Mundy GR. Chinese hamster ovarian cells transfected with the murine interleukin-6 gene cause hypercalcemia as well as cachexia, leukocytosis and thrombocytosis in tumor-bearing nude mice. Endocrinology. 1991;128:2657. - PubMed
-
- Dellon AL, Potvin C, Chretien PB. Thymus-dependent lymphocyte levels in bronchogenic carcinoma: correlations with histology, clinical stage, and clinical course after surgical treatment. Cancer. 1974;35:687. - PubMed
-
- Dewys WD, Begg C, Lavin PT, Band PR, Bennett JM, Bertino JR, Cohen MH, Douglass HO, Jr, Engstrom PE, Ezdinli EZ, Horton J, Johnson GJ, Moertel CG, Oken MM, Perlia C, Rosenbaum C, Silverstein MN, Skeel RT, Sponzo RW, Tormey DC. Prognostic effect of weight loss prior to chemotherapy in cancer patients. Am J Med. 1980;69:491. - PubMed
-
- Evans R, Duffy TM, Kamdar SJ. Differential in situ expansion and gene expression of CD4+ and CD8+ tumor-infiltrating lymphocytes following adoptive immunotherapy in a murine tumor model system. Eur J Immunol. 1991;21:1815. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources